Stanford U Sch, Falk Cardiovasular Research Ctr. — Stanford, California

Stanford U Sch, Falk Cardiovasular Research Ctr. is a clinical research site located in Stanford, California, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Stanford U Sch, Falk Cardiovasular Research Ctr. has participated in 1 clinical trials.

Therapeutic areas: Graft Rejection.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stanford U Sch, Falk Cardiovasular Research Ctr.?

Stanford U Sch, Falk Cardiovasular Research Ctr. has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stanford U Sch, Falk Cardiovasular Research Ctr. conducted?

Stanford U Sch, Falk Cardiovasular Research Ctr. has 1 clinical trials on record. Their work covers Graft Rejection.

Is Stanford U Sch, Falk Cardiovasular Research Ctr. accredited by Crixeo Health?

Stanford U Sch, Falk Cardiovasular Research Ctr. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Stanford U Sch, Falk Cardiovasular Research Ctr.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.